--- title: "Popular pre-market trades in the US stock market: Livewire pre-market down 3.40%; Applied Materials pre-market up 3.36%" type: "News" locale: "en" url: "https://longbridge.com/en/news/294516711.md" description: "Livewire pre-market down 3.40%; Applied Materials pre-market up 3.36%; Focus Media pre-market up 355.85%; Microbus pre-market up 298.67%; Replimune pre-market up 129.21%" datetime: "2026-07-31T12:58:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294516711.md) - [en](https://longbridge.com/en/news/294516711.md) - [zh-HK](https://longbridge.com/zh-HK/news/294516711.md) generator: "portal-rs" --- # Popular pre-market trades in the US stock market: Livewire pre-market down 3.40%; Applied Materials pre-market up 3.36% **Pre-market Hot Trades in US Stocks** Livewire is down 3.40% in pre-market trading. Based on recent key news: 1. On July 29, LiveWire Group received a notice from the New York Stock Exchange regarding non-compliance with listing rules related to trading stock prices, putting pressure on the stock price. This notice may raise investor concerns about the company's future compliance, thereby affecting stock performance. Source: Reuters 2. On July 28, LiveWire reported that its market share in the U.S. electric highway motorcycle market over 50 kW reached 76%, but analysts still gave it a sell rating. Despite significant market share growth, analysts remain cautious about the company's future profitability, impacting the stock price. Source: Benzinga 3. On July 29, an analyst report indicated that LiveWire was not included in the recommended buy list, leading to negative market sentiment. Analysts believe other stocks have more investment value, resulting in pressure on LiveWire's stock price. Source: MarketBeat The competition in the electric motorcycle industry is intensifying, with noticeable capital outflows. Applied Materials is up 3.36% in pre-market trading. Based on recent key news: 1. On July 30, a U.S. Congressman disclosed the purchase of Applied Materials stock, while the CEO and board members sold their shares. Analysts raised the target price and maintained a positive rating, driving the stock price up. Source: Zhitong Finance 2. On July 28, the progress of domestic semiconductor equipment in China accelerated, raising market concerns about the impact on Western equipment manufacturers' market share in China. Applied Materials faces challenges. Source: Wall Street Insights 3. On July 28, Michael Burry shorted Applied Materials due to its high valuation and risks in the Chinese market. Source: Jinshi Data AI demand drives growth in the semiconductor market, but risks remain. **Top Gainers in Pre-market US Stocks** Fenzhong Global is up 355.85% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no\_news Weibasi is up 298.67% in pre-market trading. Based on recent key news: 1. On July 30, Wetour Robotics announced a 1-for-100 share consolidation plan. This move aims to increase the stock price and improve market liquidity, expected to take effect on August 3. This news may trigger positive market expectations for the company's future development, driving the stock price up. 2. On July 29, Fermi and Galaxy Digital faced challenges amid changes in cryptocurrency regulation. Investor interest in risk assets fluctuates, which may affect related market sentiment. 3. On July 29, the performance of Teucrium Wheat Fund and Sprott Physical Silver Trust reflects market concerns about geopolitical issues and inflation, which may indirectly influence investors' allocation to other assets. The market is sensitive to changes in cryptocurrency regulation Replimune pre-market rose 129.21%. Based on recent key news: 4. On July 31, the FDA external advisory panel supported the trial results of Replimune's RP1 drug, driving the stock price up significantly. This drug is used to treat a type of skin cancer, and a final decision is expected on August 2. This news triggered a positive market reaction, with the stock price rising 129.21% in pre-market. Source: Reuters 5. On July 28, FDA reviewers expressed concerns about the efficacy of Replimune's RP1 drug, leading to a 22.6% drop in the stock price in pre-market. The review documents indicated that the trial failed to provide sufficient evidence to prove the drug's efficacy. Source: Reuters 6. On July 30, Replimune announced that the results of the FDA advisory committee meeting were favorable for the RP1 drug, and the market expects the FDA to follow the advisory panel's recommendations, resulting in a significant rebound in the stock price. Source: Reuters The biopharmaceutical industry faces regulatory challenges and high volatility ### Related Stocks - [LVWR.US](https://longbridge.com/en/quote/LVWR.US.md) - [AMAT.US](https://longbridge.com/en/quote/AMAT.US.md) - [FCUV.US](https://longbridge.com/en/quote/FCUV.US.md) - [WETO.US](https://longbridge.com/en/quote/WETO.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) ## Related News & Research - [LiveWire files Form 3 for Head of Human Resources & Systems Erica Case](https://longbridge.com/en/news/296649256.md) - [S4 Honcho™ Begins U.S. Dealer Deliveries as LiveWire Names Nationwide Giveaway Winner | LVWR Stock News](https://longbridge.com/en/news/296609703.md) - [Applied Materials Stock Is Down on Earnings. Here’s What Barchart Options Data Says Could Come Next for AMAT.](https://longbridge.com/en/news/295967382.md) - [Applied Materials stock falls after earnings weren’t quite good enough](https://longbridge.com/en/news/295845302.md) - [Bank of New York Mellon Corp Has $379.42 Million Stock Holdings in Kinder Morgan, Inc. $KMI](https://longbridge.com/en/news/296675260.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**